Search results
Jul 12, 2024 · genome institute of singapore, nanostring and next level genomics establish joint lab to further study complex diseases with spatial genomics
The Genome Institute of Singapore (GIS) is a national initiative with a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. We are the trusted producer, custodian, and curator of Singapore’s genomic data.
FACULTY Staff. The Genome Institute of Singapore has a Core Faculty who work independently as well as in collaboration with colleagues at GIS and beyond. Hailing from all around the world, our faculty bring together expertise in cancer, infectious diseases, stem cell, regenerative biology, human genetics, genomics and computational biology.
About us. VISION We read, reveal and (ω)rite DNA for a better Singapore and world. The Genome Institute of Singapore (GIS) is a national initiative with a global vision that seeks to use...
Oct 18, 2019 · SINGAPORE - Researchers in Singapore have created the world's largest genetic databank of Asian populations, which could help scientists and doctors better diagnose rare diseases, find the...
Aug 7, 2023 · The method, called Variant Network (VarNet), uses deep learning to detect cancer mutations. It is developed by scientists from the Genome Institute of Singapore (GIS), a research...
Oct 3, 2023 · The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve ...
Oct 3, 2023 · A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics. Business Wire. Tue, Oct 3, 2023,...
Jan 10, 2022 · SINGAPORE - A Singapore team of researchers is working on the next generation of mRNA vaccines that could have doses up to 100 times smaller than current ones and be cheaper to manufacture.
Jun 1, 2023 · SINGAPORE, 1 June 2023 – Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General Hospital (SGH) and their colleagues in Singapore have used artificial intelligence (AI) to accelerate the discovery of critical biomarkers that can predict, at diagnosis, patients with chronic myeloid ...
